Teva Pharmaceutical Industries
Teva Pharmaceutical’s ProAir Digihaler is a digital rescue inhaler with built-in sensors that detect the use of the inhaler and measure inspiratory flow.
Israel-based Teva designed ProAir for people with asthma and chronic obstructive pulmonary disease. The data collected from the device is sent to a mobile app where the user can review historical data and share it with healthcare providers.
ProAir Digihaler is indicated for the treatment or prevention of bronchospasm in people who have reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Teva’s ProAir won FDA approval in December 2018 and was a nominee for Prix Galien’s best medical technology awards in 2020.